Leoni Mollie's Form 4 filing
Kura Oncology, Inc. (KURA) · filed Jan 27, 2026
- Accession no.
- 0001193125-26-025303
- Filed
- Jan 27, 2026
- Trade date
- Jan 27, 2026
- Filing delay
- Same day
- Rule 10b5-1 plan
- Not checked
This filing lists 4 non-derivative transactions. Open-market sales total $69.2K. It was filed on the trade date.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Leoni MollieCIK 0002051106 | Officer (Chief Medical Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 27, 2026 | Common Stock | SSaleDisposed | −3,655 | $8.46 | −$30,921.3 | 271,799 | Direct | |
| Jan 27, 2026 | Common Stock | SSaleDisposed | −2,233 | $8.46 | −$18,891.18 | 269,566 | Direct | |
| Jan 27, 2026 | Common Stock | SSaleDisposed | −951 | $8.46 | −$8,045.46 | 268,615 | Direct | |
| Jan 27, 2026 | Common Stock | SSaleDisposed | −1,341 | $8.46 | −$11,344.86 | 267,274 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.